Literature DB >> 25547047

Predictive value of the complement system for sepsis-induced disseminated intravascular coagulation in septic patients in emergency department.

Xin Zhao1, Yun-Xia Chen1, Chun-Sheng Li2.   

Abstract

PURPOSE: To investigate changes in circulating complement component C3, membrane attack complex (MAC), and mannose-binding lectin (MBL) in patients with sepsis-induced disseminated intravascular coagulation (DIC).
MATERIALS AND METHODS: Adult septic patients admitted to the emergency department (ED) of Beijing Chao-Yang Hospital were enrolled. A DIC score of 5 or higher was considered sepsis-induced DIC. Circulating C3, MAC, and MBL levels were detected on ED arrival and compared between patients with and without DIC. The predictive value of C3, MAC, and MBL for sepsis-induced DIC at ED arrival and development of DIC after admission were assessed by receiver operating characteristic curve and logistic regression.
RESULTS: We enrolled 267 septic patients between February and December 2013. Complement 3, MAC, and MBL were higher in the DIC group (P < .01). Membrane attack complex was the independent predictor of sepsis-induced DIC. The area under the curve of MAC in predicting sepsis-induced DIC was 0.793. During hospitalization, 25 patients without DIC at enrollment developed DIC. Membrane attack complex and Sequential Organ Failure Assessment independently predicted progress to DIC. The area under the curve of MAC was 0.741.
CONCLUSIONS: Complement 3, MAC, and MBL were significantly increased in septic patients with DIC. Membrane attack complex independently predicted sepsis-induced DIC and development of DIC after ED admission.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complement; Disseminated intravascular coagulation; Sepsis

Mesh:

Substances:

Year:  2014        PMID: 25547047     DOI: 10.1016/j.jcrc.2014.11.007

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  9 in total

1.  Disseminated Intravascular Coagulation Is an Independent Predictor of Adverse Outcomes in Children in the Emergency Department with Suspected Sepsis.

Authors:  Leonora R Slatnick; Dianne Thornhill; Sara J Deakyne Davies; James B Ford; Halden F Scott; Marilyn J Manco-Johnson; Beth Boulden Warren
Journal:  J Pediatr       Date:  2020-06-14       Impact factor: 4.406

Review 2.  Could Biomarkers Direct Therapy for the Septic Patient?

Authors:  Clark R Sims; Trung C Nguyen; Philip R Mayeux
Journal:  J Pharmacol Exp Ther       Date:  2016-02-08       Impact factor: 4.030

Review 3.  Activated Complement Factors as Disease Markers for Sepsis.

Authors:  Jean Charchaflieh; Julie Rushbrook; Samrat Worah; Ming Zhang
Journal:  Dis Markers       Date:  2015-09-02       Impact factor: 3.434

4.  Complement-mediated thrombotic microangiopathy secondary to sepsis-induced disseminated intravascular coagulation successfully treated with eculizumab: A case report.

Authors:  Tomohiro Abe; Akira Sasaki; Taichiro Ueda; Yoshitaka Miyakawa; Hidenobu Ochiai
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

5.  Association between plasma complement factor H concentration and clinical outcomes in patients with sepsis.

Authors:  Junji Shimizu; Kazunori Fujino; Toshihiro Sawai; Yasuyuki Tsujita; Takahisa Tabata; Yutaka Eguchi
Journal:  Acute Med Surg       Date:  2021-01-19

Review 6.  Status of mannose-binding lectin (MBL) and complement system in COVID-19 patients and therapeutic applications of antiviral plant MBLs.

Authors:  Anita Gupta; G S Gupta
Journal:  Mol Cell Biochem       Date:  2021-03-21       Impact factor: 3.396

Review 7.  Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review.

Authors:  Mirjam Bachler; Lars M Asmis; Jürgen Koscielny; Thomas Lang; Hartmuth Nowak; Patrick Paulus; Jens-Christian Schewe; Christian von Heymann; Dietmar Fries
Journal:  Blood Coagul Fibrinolysis       Date:  2022-06-08       Impact factor: 1.061

8.  Salvianolic acid A alleviates lipopolysaccharide-induced disseminated intravascular coagulation by inhibiting complement activation.

Authors:  Qi-Yun Zhang; Jing Guo; Lin Xu; Ying Wei; Shu-Ting Zhou; Qing-Yu Lu; Li Guo; Qian-Yun Sun
Journal:  BMC Complement Med Ther       Date:  2022-09-20

Review 9.  Complement in Hemolysis- and Thrombosis- Related Diseases.

Authors:  Shanshan Luo; Desheng Hu; Moran Wang; Peter F Zipfel; Yu Hu
Journal:  Front Immunol       Date:  2020-07-10       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.